News
Maxwell hasn't seen the material herself, her attorneys said — the grand jury process is conducted behind closed doors. But ...
Convicted sex trafficker Ghislaine Maxwell wants the transcripts of testimony heard by the grand jury that indicted her to ...
Madrigal Pharmaceuticals (MDGL) stock gains as the company's Q2 2025 results exceed expectations with a 15-fold surge in ...
It comes as prosecutors in the US urge a court to release some of the records in the sex trafficking case that sent her to prison.
8h
Zacks Investment Research on MSNMadrigal (MDGL) Reports Q2 Loss, Tops Revenue EstimatesMadrigal (MDGL) came out with a quarterly loss of $1.9 per share versus the Zacks Consensus Estimate of a loss of $3.48. This compares to a loss of $7.1 per share a year ago. These figures are ...
WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Tuesday reported a loss of $42.3 million in its second quarter. The West Conshohocken, ...
Strong Q1 sales of $137.3M showcase Madrigal Pharmaceuticals, Inc.'s Rezdiffra's growth in non-cirrhotic NASH. Click for my ...
CEO touts 'amazing' sales success of new drug, but firm's stock slumps Montco firm's shares soar on huge sales increase of ...
Hong Kong-based CSPC will receive $120 million from Madrigal under the deal. Elsewhere, Apellis and PTC Therapeutics won FDA ...
Madrigal Pharmaceuticals secures $500 million credit facility to expand its MASH pipeline and refinance existing debt. Quiver AI Summary Madrigal Pharmaceuticals, Inc. has secured a $500 million ...
Madrigal plans to use the funds primarily to advance its pipeline for metabolic dysfunction-associated steatohepatitis (MASH), according to the company’s statement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results